Lobbying

Access Health's latest lobbying report covers Q3 2024, at $15K. Its first report covers Q4 2022; the issues it reports most are Health Issues.

Access Health

Latest quarter
No record
Q3 2026 · 0 reports
Last 12 months
$0
Last 4 quarters
vs last quarter
No record
Q3 2026 against the quarter before
First report
Q4 2022
The first quarter a report named it

Lobbying by quarter

Access Health lobbying by quarter
Access Health lobbying by quarter
QuarterAmountReports
Q4 2022$15K1
Q1 2023$15K1
Q2 2023$15K1
Q3 2023$15K1
Q4 2023$15K1
Q1 2024$15K1
Q2 2024$15K1
Q3 2024$15K1
Q4 2024$00
Q1 2025$00
Q2 2025$00
Q3 2025$00
Q4 2025$00
Q1 2026$00
Q2 2026$00
Q3 2026$00

By issue

  • Health issues$105K · 7 reports

An issue's amount splits each report's amount equally over the issues the report lists.

Who was lobbied

  • HOUSE OF REPRESENTATIVES7 reports
  • SENATE7 reports

Firms it paid

Firm
Potomac Strategic Development Company$120K8 quarters

Former officials lobbying for it

No lobbyist with a covered position.

Lobbying reports

Filed by
24/11/04for Q3 2024Potomac Strategic Development Company$15K
24/08/04for Q2 2024Potomac Strategic Development Company$15K
24/05/11for Q1 2024Potomac Strategic Development Company$15K
24/02/05for Q4 2023Potomac Strategic Development Company$15K
23/11/20for Q3 2023Potomac Strategic Development Company$15K
23/08/07for Q2 2023Potomac Strategic Development Company$15K
23/05/03for Q1 2023Potomac Strategic Development Company$15K
23/02/09for Q4 2022Potomac Strategic Development Company$15K